Last updated: 5 September 2024 at 9:45am EST

Elizabeth G Nabel Net Worth




The estimated Net Worth of Elizabeth G Nabel is at least $8.63 Millón dollars as of 3 September 2024. Elizabeth Nabel owns over 2,179 units of Accolade stock worth over $147,114 and over the last 10 years Elizabeth sold ACCD stock worth over $8,477,964.

Elizabeth Nabel ACCD stock SEC Form 4 insiders trading

Elizabeth has made over 15 trades of the Accolade stock since 2020, according to the Form 4 filled with the SEC. Most recently Elizabeth exercised 2,179 units of ACCD stock worth $8,520 on 3 September 2024.

The largest trade Elizabeth's ever made was selling 73,975 units of Accolade stock on 15 July 2020 worth over $6,497,964. On average, Elizabeth trades about 3,422 units every 38 days since 2015. As of 3 September 2024 Elizabeth still owns at least 37,625 units of Accolade stock.

You can see the complete history of Elizabeth Nabel stock trades at the bottom of the page.



What's Elizabeth Nabel's mailing address?

Elizabeth's mailing address filed with the SEC is C/O ACCOLADE, INC., 1201 THIRD AVENUE, SUITE 1700, SEATTLE, WA, 98101.

Insiders trading at Accolade

Over the last 4 years, insiders at Accolade have traded over $9,006,680 worth of Accolade stock and bought 74 units worth $743 . The most active insiders traders include Edgar Jr Bronfman, Jeffrey D Jordan y Dawn G Lepore. On average, Accolade executives and independent directors trade stock every 5 days with the average trade being worth of $18,928. The most recent stock trade was executed by Rajeev Singh on 3 September 2024, trading 3,786 units of ACCD stock currently worth $14,803.



What does Accolade do?

Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.



Complete history of Elizabeth Nabel stock trades at Medtronic Plc, Moderna Inc y Accolade

Persona
Trans.
Transacción
Precio total
Elizabeth G Nabel
Director
Uso de opción $9,609
3 Sep 2024
Elizabeth G Nabel
Director
Uso de opción $32,922
6 Aug 2024
Elizabeth G Nabel
Director
Uso de opción $15,427
31 May 2024
Elizabeth G Nabel
Director
Uso de opción $17,948
29 Feb 2024
Elizabeth G Nabel
Director
Uso de opción $15,286
30 Nov 2023
Elizabeth G Nabel
Director
Uso de opción $23,634
31 Aug 2023
Elizabeth G Nabel
Director
Uso de opción $189,669
25 Jul 2023
Elizabeth G Nabel
Director
Uso de opción $21,094
31 May 2023
Elizabeth G Nabel
Director
Uso de opción $25,713
21 Jul 2022
Elizabeth G Nabel
Director
Uso de opción $16,940
22 Jul 2021
Elizabeth G Nabel
Director
Uso de opción $91,500
3 May 2024
Elizabeth G Nabel
Director
Uso de opción $89,036
28 Apr 2023
Elizabeth G Nabel
Director
Uso de opción $100,192
28 Apr 2022
Elizabeth G Nabel
Director
Venta $6,497,964
15 Jul 2020
Elizabeth G Nabel
Director
Venta $1,980,000
12 May 2020


Accolade executives and stock owners

Accolade executives and other stock owners filed with the SEC include: